Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion (CRVO)
Clinical trial NCT01303276 · UNKNOWN
Trial details
- NCT number
- NCT01303276
- Sponsor
- University of Toronto
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2011-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.